Search Within

Kenneth Ho-Ming Yu

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (14)
Groups
  1. Center for Pancreatic Cancer Research (34)
  2. Department of Medicine (34)
  3. Gastrointestinal Oncology Service (34)
  4. Population Sciences Research Program (34)
  5. Solid Tumor Oncology Division (34)
  6. Biostatistics Service (24)

More Groups

People
  1. Eileen O'Reilly (34)
  2. Anna Varghese (22)
  3. David Kelsen (21)
  4. Zsofia Stadler (21)
  5. Marinela Capanu (19)
  6. Wungki Park (17)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Cancer (5)
  3. Clinical Cancer Research (2)
  4. JNCI: Journal of the National Cancer Institute (2)
  5. Annals of Surgery (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Wiley Blackwell (6)
  3. Oxford University Press (3)
  4. American Association for Cancer Research (2)
  5. American Medical Association (2)
  6. Adis Data Information Bv (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Identification of germline genetic mutations in patients with pancreatic adenocarcinoma
    Meeting Abstract

    Salo-Mullen, E. E.; O'Reilly, E. M.; Kelsen, D. P.; Lowery, M. A.; Yu, K. H.; Rau-Murthy, R.; Siegel, B.; Saltz, L.; Kurtz, R. C.; Offit, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • An emerging entity: Pancreatic adenocarcinoma associated with a known brca mutation: Clinical descriptors, treatment implications, and future directions
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Stadler, Z. K.; Yu, K. H.; Janjigian, Y. Y.; Ludwig, E.; D'adamo, D. R.; Salo-Mullen, E.; Robson, M. E.; Allen, P. J.; more...
    The Oncologist (2011)

    Fulltext@MSK | Save